Sarah W Huf1,2,3,4, David A Asch5,6,7,8, Kevin G Volpp5,6,7,8, Catherine Reitz5,6,7, Shivan J Mehta5,6,7. 1. Center for Health Care Innovation, University of Pennsylvania, Philadelphia, PA, USA. s.huf@imperial.ac.uk. 2. The Commonwealth Fund, Harkness Fellowship, New York City, NY, USA. s.huf@imperial.ac.uk. 3. Department of Surgery and Cancer, Imperial College London, London, UK. s.huf@imperial.ac.uk. 4. Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. s.huf@imperial.ac.uk. 5. Center for Health Care Innovation, University of Pennsylvania, Philadelphia, PA, USA. 6. Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. 7. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 8. Center for Health Equity Research and Promotion, Philadelphia VA Medical Center, Philadelphia, PA, USA.
Abstract
BACKGROUND: Routine screening reduces colorectal cancer mortality, but screening rates fall below national targets and are particularly low in underserved populations. OBJECTIVE: To compare the effectiveness of a single text message outreach to serial text messaging and mailed fecal home test kits on colorectal cancer screening rates. DESIGN: A two-armed randomized clinical trial. PARTICIPANTS: An urban community health center in Philadelphia. Adults aged 50-74 who were due for colorectal cancer screening had at least one visit to the practice in the previously year, and had a cell phone number recorded. INTERVENTIONS: Participants were randomized (1:1 ratio). Individuals in the control arm were sent a simple text message reminder as per usual practice. Those in the intervention arm were sent a pre-alert text message offering the options to opt-out of receiving a mailed fecal immunochemical test (FIT) kit, followed by up to three behaviorally informed text message reminders. MAIN MEASURES: The primary outcome was participation in colorectal cancer screening at 12 weeks. The secondary outcome was the FIT kit return rate at 12 weeks. KEY RESULTS: Four hundred forty participants were included. The mean age was 57.4 years (SD ± 6.1). 63.4% were women, 87.7% were Black, 19.1% were uninsured, and 49.6% were Medicaid beneficiaries. At 12 weeks, there was an absolute 17.3 percentage point increase in colorectal cancer screening in the intervention arm (19.6%), compared to the control arm (2.3%, p < 0.001). There was an absolute 17.7 percentage point increase in FIT kit return in the intervention arm (19.1%) compared to the control arm (1.4%, p < 0.001). CONCLUSIONS: Serial text messaging with opt-out mailed FIT kit outreach can substantially improve colorectal cancer screening rates in an underserved population. TRIAL REGISTRATION: clinicaltrials.gov ( https://clinicaltrials.gov/ct2/show/NCT03479645 ).
BACKGROUND: Routine screening reduces colorectal cancer mortality, but screening rates fall below national targets and are particularly low in underserved populations. OBJECTIVE: To compare the effectiveness of a single text message outreach to serial text messaging and mailed fecal home test kits on colorectal cancer screening rates. DESIGN: A two-armed randomized clinical trial. PARTICIPANTS: An urban community health center in Philadelphia. Adults aged 50-74 who were due for colorectal cancer screening had at least one visit to the practice in the previously year, and had a cell phone number recorded. INTERVENTIONS: Participants were randomized (1:1 ratio). Individuals in the control arm were sent a simple text message reminder as per usual practice. Those in the intervention arm were sent a pre-alert text message offering the options to opt-out of receiving a mailed fecal immunochemical test (FIT) kit, followed by up to three behaviorally informed text message reminders. MAIN MEASURES: The primary outcome was participation in colorectal cancer screening at 12 weeks. The secondary outcome was the FIT kit return rate at 12 weeks. KEY RESULTS: Four hundred forty participants were included. The mean age was 57.4 years (SD ± 6.1). 63.4% were women, 87.7% were Black, 19.1% were uninsured, and 49.6% were Medicaid beneficiaries. At 12 weeks, there was an absolute 17.3 percentage point increase in colorectal cancer screening in the intervention arm (19.6%), compared to the control arm (2.3%, p < 0.001). There was an absolute 17.7 percentage point increase in FIT kit return in the intervention arm (19.1%) compared to the control arm (1.4%, p < 0.001). CONCLUSIONS: Serial text messaging with opt-out mailed FIT kit outreach can substantially improve colorectal cancer screening rates in an underserved population. TRIAL REGISTRATION: clinicaltrials.gov ( https://clinicaltrials.gov/ct2/show/NCT03479645 ).
Authors: Gillian Libby; Jane Bray; Jennifer Champion; Linda A Brownlee; Janice Birrell; Dermot R Gorman; Emilia M Crighton; Callum G Fraser; Robert J C Steele Journal: J Med Screen Date: 2011 Impact factor: 2.136
Authors: Carlo Senore; Andrea Ederle; Giovanni DePretis; Corrado Magnani; Debora Canuti; Silvia Deandrea; Manuel Zorzi; Alessandra Barca; Piero Bestagini; Katia Faitini; Luigi Bisanti; Coralba Casale; Antonio Ferro; Paolo GiorgiRossi; Francesco Quadrino; Giorgia Fiorina; Arianna Capuano; Nereo Segnan; Alberto Fantin Journal: Prev Med Date: 2015-01-17 Impact factor: 4.018
Authors: Sarah Huf; Robert S Kerrison; Dominic King; Tim Chadborn; Adele Richmond; Deborah Cunningham; Ellis Friedman; Heema Shukla; Fu-Min Tseng; Gaby Judah; Ara Darzi; Ivo Vlaev Journal: Prev Med Date: 2020-06-29 Impact factor: 4.018
Authors: Idris Guessous; Chiranjeev Dash; Pauline Lapin; Mary Doroshenk; Robert A Smith; Carrie N Klabunde Journal: Prev Med Date: 2009-12-16 Impact factor: 4.018
Authors: David W Baker; Tiffany Brown; David R Buchanan; Jordan Weil; Kate Balsley; Lauren Ranalli; Ji Young Lee; Kenzie A Cameron; M Rosario Ferreira; Quinn Stephens; Shira N Goldman; Alred Rademaker; Michael S Wolf Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Amelia Acera; Josep Maria Manresa; Diego Rodriguez; Ana Rodriguez; Josep Maria Bonet; Norman Sanchez; Pablo Hidalgo; Pilar Soteras; Pere Toran; Marta Trapero-Bertran; Iris Lozano; Silvia De Sanjose Journal: BMC Womens Health Date: 2014-07-16 Impact factor: 2.809
Authors: Jordan J Karlitz; A Mark Fendrick; Jay Bhatt; Gloria D Coronado; Sushanth Jeyakumar; Nathaniel J Smith; Marcus Plescia; Durado Brooks; Paul Limburg; David Lieberman Journal: Popul Health Manag Date: 2021-12-24 Impact factor: 2.290